The University of Southern California recently received a new research grant worth $5.6 million from the National Institutes of Health for the USC Norris Comprehensive Cancer Center. The administering organization was the National Cancer Institute, and the project leader is Dr. Stephen Gruber, a Professor of Medicine at the Keck School of Medicine and the H. Leslie Hoffman and Elaine S. Hoffman Chair in Cancer Research.
Science Market Update
The University of Southern California received $50 million in bioscience funding earlier this year from retired orthopedic spinal surgeon, Gary K. Michelson, to fund the USC Michelson Center for Convergent Bioscience. The new research building will be used by USC research lab scientists and engineers to produce groundbreaking research in health and similar sciences. One of the center’s aims is to turn biological sciences “into a quantitative and predictive science” and bring about new therapies and cures for diseases.
Are you struggling to find answers to your research challenges? Tired of using outdated technologies, techniques, and equipment? We may able to help. Biotechnology Calendar, Inc. would like to invite you to the 33rd semiannual Biotechnology Vendor Showcase™ Event on Thursday, April 3, 2014.
UCLA Market Highlights
With annual research expenditures of over $1 billion and one of the largest medical centers in the nation, Los Angeles provides one of the most active, research marketplace opportunities in the nation.
17 Fast Facts about UCLA Marketplace:
Biotechnology Calendar, Inc. is hosting the 10th Semiannual BioResearch Product Faire™ Event at the University of Southern California Health Sciences Campus on Wednesday, April 2, 2014. USC is a rich lab supply marketplace packed with enthusiastic researchers.
Are you curious about the latest laboratory technology, how to save time and stock your lab with economical science solutions? Biotechnology Calendar, Inc. Lab Product Expos provide you with answers. Researchers at the University of Southern California are invited to attend our Southern California Health Science BioResearch Product Faire™ Event on April 2nd, 2014.
Two UCLA Researchers recently received major multimillion dollar stem cell grants to help bring the benefits of new stem cell research to patients. These grants will fund two groundbreaking clinical trials set to begin in the beginning of 2014.
UCLA researchers have developed an innovative approach to diagnosing cancer. This research has excellent commercial applications and is already in the process of being translated into a novel technology by a Los Angeles start up. The new technique allows researchers to very accurately diagnose cancers by observing the physical characteristics of cells in bodily fluids.
University of California life science researchers at the Jonsson Comprehensive Cancer Center have recently developed a novel and innovative cancer therapy approach that uses nanotechnology to fight brain cancer. This new technology uses nanotechnology structures called “nanodiamonds” to deliver chemotherapy agents directly to the cancerous areas in brain cancer patients.
“As many as 5 million Americans face the challenge of Alzheimer’s disease, which robs them of their memories, their independence, and ultimately, their lives. We are determined, even in a time of constrained fiscal resources, to capitalize on exciting scientific opportunities to advance understanding of Alzheimer’s biology and find effective therapies as quickly as possible.”